Based on the transcriptome results and relevant literature on NB (22–27), we selected 6 reported differentially expressed genes, namely MGST1, SERPINE1, IGF2, CIP2A, CHL1, and ERBB3 for RT-PCR validation. The gene discussed is CHL1; the disease is neuroblastoma.